Moderna股价上周飙升18%，收于逾四年来最高水平。此前《纽约时报》周五报道称，美国国立卫生研究院正筹划一项公私合作计划，以加速癌症疫苗的研发进程。与此同时，Moderna股票还获纳入纳斯达克100指数，取代被Paramount Skydance收购的Warner Bros. Discovery。
这家疫苗制造商的股票今年以来表现抢眼，累计涨幅超过600%，再度逼近其疫情时期的高点。8月份股价再度起飞，当时Moderna与默沙东表示，双方联合开发的个性化mRNA癌症疫苗在针对特定黑色素瘤患者的3期试验中，延缓了癌症复发或扩散。两家公司计划于本月晚些时候公布完整数据，并正在为明年该药物的监管审批做准备。
默沙东股价周五上涨2.3%。BioNTech正在开发针对胰腺癌的类似疫苗，其美股上涨逾5%。Novavax目前生产传染病疫苗，但正在探索癌症疫苗的可能性，其股价攀升16%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.